Inhibition of CatA: an emerging strategy for the treatment of heart failure. - Wikidata - wikimedia - TriplyDB

Inhibition of CatA: an emerging strategy for the treatment of heart failure.

Inhibition of CatA: an emerging strategy for the treatment of heart failure.

http://www.wikidata.org/entity/Q34621201

about

Proteolytic Activation of Human Cathepsin A Cathepsin A inhibition attenuates myocardial infarction-induced heart failure on the functional and proteomic levels Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014).The importance of drug discovery for treatment of cardiovascular diseases.Tolerability, safety, and pharmacokinetics of the novel cathepsin A inhibitor SAR164653 in healthy subjects.Cathepsin A mediates susceptibility to atrial tachyarrhythmia and impairment of atrial emptying function in Zucker diabetic fatty rats.

P2860

Q27682025-4DF18DED-056A-408C-BDCE-CFBF918EE091 Q36955513-D9BC1D25-5552-46BB-8F12-E3A22656C2A3 Q38546917-53DB04E6-0857-4BDB-82AB-8B32D5B627BB Q51476385-D52D6658-C925-4D13-805F-049B80FC57A2 Q53113480-DA3A335F-74E7-4C4C-B58B-DD6D197151E7 Q53133810-BB5BDB49-3939-4256-93C4-57B16FC27676

P2860

Inhibition of CatA: an emerging strategy for the treatment of heart failure.

http://www.wikidata.org/entity/Q34621201

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Inhibition of CatA: an emerging strategy for the treatment of heart failure.

@ast

Inhibition of CatA: an emerging strategy for the treatment of heart failure.

@en

Inhibition of CatA: an emerging strategy for the treatment of heart failure.

@nl

type

label

Inhibition of CatA: an emerging strategy for the treatment of heart failure.

@ast

Inhibition of CatA: an emerging strategy for the treatment of heart failure.

@en

Inhibition of CatA: an emerging strategy for the treatment of heart failure.

@nl

prefLabel

Inhibition of CatA: an emerging strategy for the treatment of heart failure.

@ast

Inhibition of CatA: an emerging strategy for the treatment of heart failure.

@en

Inhibition of CatA: an emerging strategy for the treatment of heart failure.

@nl

P1433

Q34621201-316FBF26-49D7-42B6-AB2E-839A37AE8B5C

P1476

Q34621201-A8DF7CCA-37F5-4F60-B463-F8DC2DEFB0EB

P2093

Q34621201-0256FFB8-8BD9-4C1F-82B5-DCD6E7ECC4E6

Q34621201-7FB38E7D-62D5-4038-97C1-2DCD5709DAC3

Q34621201-7FF8D4D3-748D-4F5E-B97E-37A0A2945969

Q34621201-8EBC3DDA-D215-4F76-A7A4-9BD23C6DABBF

Q34621201-901F43C1-B66C-4F9C-B066-F26E1E37B1A0

Q34621201-A0F7CB67-C402-414D-988A-823E63679199

Q34621201-A91407ED-581A-4704-8E65-B22AD6C66A15

Q34621201-C9E63DFB-7B48-4372-AA69-841D82F2278A

P2860

Q34621201-05D9D01D-FABE-409B-A81C-A2157BD5820B

Q34621201-0887A525-5617-4A0C-A963-345E7C1770A7

Q34621201-0D000BF8-66A4-45AB-BB27-D14AD55D0D15

Q34621201-0D5B934A-86A8-439B-B016-EFF9375D37DE

Q34621201-18F635D6-B06C-4423-B128-5261A6D21226

Q34621201-1A595D94-2006-492F-B0C9-8AD1F2777121

Q34621201-2230939B-D8A1-42E0-AB99-EF03AFEF8F3A

Q34621201-25753A21-4C8D-4942-BED3-309AD998BC08

Q34621201-35E49ED3-EB47-4026-9D0A-B9F89D7C28C4

Q34621201-38A400F4-4FFF-4554-A207-45047EB5D349

P304

Q34621201-DA17C6F3-9FED-4617-ADCD-77F34856E7CC

P31

Q34621201-487311E7-24E2-45AF-A196-C577FA48F9B2

P356

Q34621201-453B9F03-B4E7-4220-8653-4079D5304CCC

P433

Q34621201-02C5D5B0-518B-4E34-8711-711BC79FD28F

P478

Q34621201-50A49CC9-9770-4D8A-BC91-9F8F547E4D0C

P50

Q34621201-89C86DCD-B871-4FB5-B350-4CF975A8D935

P577

Q34621201-13CF99C8-5B2B-484F-A0ED-C119CBBDFBEF

P5875

Q34621201-C08D3A9C-2E5F-488C-9499-465F7D2043D0

P698

Q34621201-7116895E-08D0-42E5-9D14-4A24B3412D2B

P921

Q34621201-1657EBA2-37C0-451F-A5A9-EE0F8CE4A6DC

P356

P1433

Future Medicinal Chemistry

P1476

Inhibition of CatA: an emerging strategy for the treatment of heart failure

@en

P2093

Christian Buning

http://www.w3.org/2001/XMLSchema#string

Dominik Linz

http://www.w3.org/2001/XMLSchema#string

Hartmut Ruetten

http://www.w3.org/2001/XMLSchema#string

Klaus Wirth

http://www.w3.org/2001/XMLSchema#string

Sven Ruf

http://www.w3.org/2001/XMLSchema#string

Thomas Hübschle

http://www.w3.org/2001/XMLSchema#string

Thorsten Sadowski

http://www.w3.org/2001/XMLSchema#string

Wolfgang Linz

http://www.w3.org/2001/XMLSchema#string

P2860

Cathepsin A regulates chaperone-mediated autophagy through cleavage of the lysosomal receptor

Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977

Novel β-amino acid derivatives as inhibitors of cathepsin A

Three-dimensional structure of the human 'protective protein': structure of the precursor form suggests a complex activation mechanism

Facilitation of renal kallikrein-kinin system prevents the development of hypertension by inhibition of sodium retention

Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages

Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1

Lysosomal sialidase (neuraminidase-1) is targeted to the cell surface in a multiprotein complex that facilitates elastic fiber assembly

Association of N-acetylgalactosamine-6-sulfate sulfatase with the multienzyme lysosomal complex of beta-galactosidase, cathepsin A, and neuraminidase. Possible implication for intralysosomal catabolism of keratan sulfate

Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

P304

399-409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC.13.24

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Herman A Schreuder

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236050099

http://www.w3.org/2001/XMLSchema#string

P698

23495688

http://www.w3.org/2001/XMLSchema#string

P921